US 12,453,764 B2
Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof
Bruce D. Forrest, South Nyack, NY (US)
Assigned to Eva Barbara Schadeck, South Nyack, NY (US)
Filed by Eva Barbara Schadeck, South Nyack, NY (US)
Filed on Apr. 16, 2024, as Appl. No. 18/636,759.
Application 18/636,759 is a continuation of application No. 17/569,304, filed on Jan. 5, 2022, granted, now 11,986,519.
Application 17/569,304 is a continuation of application No. 16/482,632, granted, now 11,246,918, previously published as PCT/US2018/016563, filed on Feb. 2, 2018.
Claims priority of provisional application 62/454,598, filed on Feb. 3, 2017.
Prior Publication US 2024/0366744 A1, Nov. 7, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 39/102 (2006.01); A61P 31/04 (2006.01); A61K 39/00 (2006.01)
CPC A61K 39/102 (2013.01) [A61P 31/04 (2018.01); A61K 2039/55505 (2013.01); A61K 2039/575 (2013.01); A61K 2039/6018 (2013.01); A61K 2039/6037 (2013.01); A61K 2039/6068 (2013.01)] 27 Claims
 
1. A pharmaceutical composition comprising
an immunogenic saccharide-lipid conjugate comprising a Haemophilus influenzae serotype a capsular polysaccharide, fragment thereof, or combination thereof conjugated to a lipid.